Every now and then my mouth gapes open with I read a paper. While the limitations of this paper must be noted – a small sample set involving three case reports – its conclusion – a very rapid return to health of people with severe long-term COVID...
Filling a Gaping Hole ME/CFS organizations have been doing something different lately. Long focused purely on research, they’ve been putting more resources into treatment trials lately – suggesting they feel more confident about moving forward in that...
Medication and Treatment Decisions – Navigating Online (mis)Information & Evaluating the Evidence What to do when robust evidence; i.e. evidence-based medicine – medicine that has been thoroughly assessed by scientific studies – just isn’t...
It’s amazing sometimes what you see if you look. A blog on the causes and possible treatments for the very troubling photophobia, or light sensitivity, that some experience turned into a deep dive into migraine and its similarities to diseases like chronic...
Bringing a new drug combination to market is not easy. First, it requires creativity and initiative. Dr. Skip Pridgen was nothing if not creative when he put together a two-drug combo antiviral (valacyclovir) and an anti-inflammatory with antiviral properties...
Mary Anne Fletcher (1937-2023) – In Memoriam I only met Mary Anne a few times, but they were vivid. I remember – years ago – watching with a little awe as she boldly and vociferously called for NIH-funded treatment trials for ME/CFS. She...